Breast-Cancer Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)

H

• health-care (1)

• hiv (7)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• liver (2)

• lung-cancer (2)

• lupus (1)

M

• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pain (29)

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

• skin (1)

• sports (3)

T

• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma (2006)

    A comparison of antitumor properties of different cannabinoids. The results obtained show that cannabidiol is the most potent inhibitor of the growth of cancer cells. View study

  • Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells (2007)

    CBD would help treat breast cancer since it can significantly decrease the development of metastatic cells. View study

  • Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition (2010)

    Preclinical evidence indicating the possible efficacy of the use of cannabidoids in the treatment of ErbB2-positive breast cancer, characterized by highly aggressive phenotypes and a reduced response to standard therapies. View study

  • Cannabinoids: A new hope for breast cancer therapy (2012)

    Cannabinoid-based drugs may be useful for the treatment of most subtypes of mammary tumors. View study

  • Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent (2016)

    Treatment with JWH-015 was able to significantly decrease the primary tumor burden and the metastasis of luciferase-labeled murine breast carcinoma 4T1 cells in immunocompetent mice in vivo. It also reduced the viability of murine 4T1 and MCF7 breast carcinoma cells in vitro by inducing apoptosis. Based on these results, JWH-015 and other selective CB2 agonists (cannabinoid receptor 2) demand attention as adjuvant therapies, particularly in patients undergoing bone metastases where the CB2-selective compounds can not only improve the outcome of the disease but also increase the quality of life of the patient. View study

  • Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer (2009)

    This research was based on the study about the effects and mechanism of action of synthetic non-psychotic cannabinoids on the growth of breast cancer and metastasis. The results indicate that CB1 and CB2 receptors could be used to develop new therapeutic strategies against the growth of breast cancer and metastasis. View study

  • Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer (2014)

    It could be concluded in this review that the development of compounds that can simultaneously attack multiple anti-tumor cannabinoid pathways efficiently can provide a novel approach for the treatment of patients with metastatic breast cancer. View study